Add to my selection

AMELUZ (acide 5-aminolévulinique (chlorhydrate de l'))

Medicine - Posted on Nov 28 2024

Active substance (DCI)

acide 5-aminolévulinique (chlorhydrate de l')

history (3)

10/23/24

AMELUZ (5-aminolevulinic acid) - Basal cell carcinomas

Summary of opinion Favourable opinion for reimbursement only in the treatment of superficial basal cell carcinoma unsuitable...

CAV :
54321

icône flèche
10/23/24

AMELUZ (5-aminolevulinic acid) - Actinic keratoses

Summary of opinion Favourable opinion for reimbursement in the “treatment of actinic keratosis of mild to moderate severity ...

CAV :
54321

icône flèche
2/3/16

AMELUZ (5-aminolaevulinic acid), photodynamic therapy

No clinical benefit demonstrated over METVIXIA in the treatment of actinic keratosis on the face and scalp. AMELUZ has Marke...

CAV :
54321

icône flèche

Technical information

ATC code

L01XD04

Manufacturer

BIOFRONTERA PHARMA GMBH

Presentation

AMELUZ 78 mg/g, gel (code CIS : 65115071)
1 tube aluminium de 2 g (CIP : 34009 300 013 8 7)

All our publications

Skin and connective tissue cancers

Skin and connective tissue diseases